目 录
一、概述····················································································································································1
二、药代动力学研究生物样品分析方法的建立和确证···············································2
(一)常用分析方法·················································································································2
(二)方法学确证······················································································································2
1、特异性······································································································································3
2、标准曲线和定量范围······································································································3
3、定量下限·································································································································4
4、精密度与准确度·················································································································4
5、样品稳定性···························································································································5
6、提取回收率··························································································································5
7、微生物学和免疫学分析·······························································································5
8、方法学质控··························································································································6
(三)分析数据的记录与保存··························································································6
1、方法建立与确认的数据·······························································································7
2、样品分析的数据···············································································································7
3、其他相关信息·····················································································································7
三、药代动力学研究的具体内容·····························································································7
(一)健康志愿者药代动力学研究················································································8
1、单次给药药代动力学研究··························································································8
2、多次给药药代动力学研究·························································································11
3、进食对口服药物制剂药代动力学影响的研究···············································13
4、药物代谢产物的药代动力学研究··········································································14
5、药物-药物的药代动力学相互作用研究······························································14
(二)目标适应症患者的药代动力学研究································································15
化学药物临床药代动力学研究技术指导原则_药学_医药卫生_专业资料 暂无评价0人阅读0次下载举报文档 化学药物临床药代动力学研究技术指导原则_药学_医药卫生_专业...
化学药物非临床药代动力学研究技术指导原则_药学_医药卫生_专业资料 暂无评价0人阅读0次下载举报文档 化学药物非临床药代动力学研究技术指导原则_药学_医药卫生...
儿科人群化学药物药代动力学研究技术指导原则 国家食品药品监督管理局药品审评中心...14? 一、概述 临床药代动力学研究(Clinical pharmacokinetic studies)旨在阐明药物...
(二)适用范围本指导原则适用于兽用化学药物在靶动物进行临床药代动力学研究。 各试验 单位可根据不同药品的特点,参考本技术指导原则,科学合理地进行试验设计, 并...
化学药物临床试验报告的结构与内容技术指导原则一、概述 临床试验报告是对药物临床...本指导原则包括了以下的临床研究: 期临床试验(耐受性试验和临床药代动力学试验)...
16 化学药物制剂研究基本技术指导原则一、概述药物必须制成适宜的剂型才能用于临床...随着研究的进展,在完成有关临床研究(如药代动力学试验、 生物利用度比较研究)...
临床药代动力学研究要点_医药卫生_专业资料。今日推荐 78份文档 不...23页 免费 3. 兽用化学药物临床药代... 10页 免费喜欢此文档的还喜欢 ...
兽用化学药物非临床药代动力学试验指导原则一、概述(一)定义与目的非临床药代动力学研究是指通过实验动物(有时还有靶动物)体内、外及靶 动物体外的试验, 获取...
化学药物一般药理学研究技术指导原则_药学_医药卫生_专业资料。指导原则编号: 【...化学药物非临床药代动力... 23页 免费 化学药物口服缓控释制剂... 21页 免费...
关 于这几类临床研究的具体技术要求,请参阅相关的指导原则。本指导 原则主要...33页 免费 化学药物临床药代动力学... 23页 免费喜欢此文档的还喜欢 ...
热门文档